what's next?, page-3

Hi, harrydent, I do not believe Either of the two products into and at the final hurdle have been been factored in s/p wise. My reason for that is , Biotechs are not like mining ,retail, banks etc. until you cross that line only then the real action begins especially what we have to offer.. For the last 12 months announcements have had little effect on our share price because its controlled , I believe thats not a bad thing if they continue to build thier position there is only one way and thats positive .. Shorters.. I do not think they are still active , here is a quote from a well known prophfet group last week ...." In what is already a thinly traded stock as the market continues to digest positive news flow about MSB,s pipline of products we expect these shorts will inevitably get " squeezed" and disappear ".... Takeover! there is a reason lots of companies hold 19.9% of another company as TEVA does.(there is a corporate law reason there ) My belief is its way to early for another company to go near this at present for much the same reasons mentioned before Bios, are one of a kind ..Also when the time comes to look at a takeover, there are two friends to get around and one has his sights on reg. med. evolution, they hold over 30% of MSB ..What was that market cap... Cheers Vin